The aim of the investigation was to find a suitable approach for assessing inhalation exposure of urban inhabitants to polycyclic aromatic hydrocarbons (PAHs) in air. Personal exposure to PAHs of fifteen subjects, Zagreb inhabitants, was measured over a week in summer and again in winter. All subjects kept a diary of motion and activities and filled in a questionnaire on the characteristics of their fiat and household members. PAHs concentrations inside and outside subject's homes were simultaneously measured as were those in the working environment and in transport. Using an exposure model which takes into account the time spent by the subjects in each microenvironment and the respective concentrations measured, the inhalation exposure of each subject was calculated and compared with the directly measured personal exposure for the winter season only the summer concentrations being negligible. For a few subjects the calculated inhalation exposure deviated considerably from the one measured directly. This could be attributed to the fact that the subject spent some time in a microenvironment with significantly different PAH levels which were not included in the calculation. However, if the average results for the whole group are considered, there was no statistically significant difference between the directly measured and calculated PAH inhalation exposures. Therefore the described approach could be used for calculating average inhalation exposure to PAHs of population groups with common characteristics.

Download full-text PDF

Source

Publication Analysis

Top Keywords

inhalation exposure
20
exposure
8
polycyclic aromatic
8
aromatic hydrocarbons
8
personal exposure
8
exposure pahs
8
directly measured
8
inhalation
6
measured
6
assessment human
4

Similar Publications

Methyltrimethoxysilane (MTMS).

Toxicol Ind Health

January 2025

Cincinnati, OH, USA.

Methyltrimethoxysilane (MTMS) has been used as a coupling agent in thermoplastics and thermosetting resins, a cross-linker in silicone sealants, a water repellent component, and in silicone hard-coats for plastics. Acute studies in experimental animals showed a low order of toxicity for MTMS via oral, dermal, and inhalation routes. MTMS was slightly irritating to both eyes and skin in rabbits.

View Article and Find Full Text PDF

Tanimilast is an inhaled phosphodiesterase-4 inhibitor currently in phase III clinical development for treating chronic obstructive pulmonary disease and asthma. This trial aimed to characterize the pharmacokinetics, mass balance, and metabolite profiling of tanimilast. Eight healthy male volunteers received a single dose of nonradiolabeled tanimilast via powder inhaler (Chiesi NEXThaler [3200 μg]), followed by a concomitant intravenous infusion of a microtracer ([C]-tanimilast: 18.

View Article and Find Full Text PDF

The assessment of humans indirectly exposed to chemicals via the environment (HvE) is an assessment element of the Registration, Evaluation, Authorisation, and Restriction of Chemicals (REACH) regulation. The European Union System for the Evaluation of Substances (EUSES) is the default screening tool, aimed at prioritizing chemicals for further refinement/higher tier assessment. This review summarizes the approach used in EUSES, evaluates the state of the science in human exposure modeling via the environment, and identifies areas for further research to strengthen the confidence and applicability of EUSES for assessing HvE.

View Article and Find Full Text PDF

This study aimed to evaluate the concentrations of sulfur dioxide (SO2) and nitrogen oxides (NOX) around the Qom (a province in Iran) combined cycle power plant in relation to seasonal variations and fuel type from December 2014 to May 2015. Passive sampling was used in three monitoring sites around the power plant to assess noncarcinogenic health risks associated with exposure to SO2 and NOX. Results showed the higher concentrations of NOX and SO2 in winter than in spring.

View Article and Find Full Text PDF

Cota is a lipidated dual GLP-1 and Glucagon receptor agonist that was investigated for the treatment of various metabolic diseases, it is designed for once daily subcutaneous administration. Invasive daily injections often result in poor patient compliance with chronic disease, and here, we demonstrate an innovative strategy of encapsulating reversible cota self-assembled fibers within an in-situ forming depot of low molecular weight poly(lactic-co-glycolic) acid (LWPLGA) for sustained delivery GLP-1 and Glucagon receptor agonist with controlled burst release. This could be a suitable alternative to other sustained delivery strategies for fibrillating peptides.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!